期刊
CLINICAL & TRANSLATIONAL ONCOLOGY
卷 15, 期 6, 页码 417-424出版社
SPRINGER INT PUBL AG
DOI: 10.1007/s12094-012-0982-0
关键词
Basal cell carcinomas (BCC); Squamous cell carcinomas (SCC); Lipid nanoemulsions (NEs) and nanoparticles (NPs); Nanocarriers; Non-melanoma skin cancer
类别
资金
- CAPES (Coordenacao Aperfeicoamento de Pessoal de Nivel Superior)
- FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)
Basal cell carcinomas and squamous cell carcinomas are non-melanoma skin cancers reported to be among the most common malignancies, being responsible for high human morbidity. Conventional chemotherapy applied to these conditions shows non-specific targeting, thus severe adverse side effects are also commonly reported. New therapeutic strategies based on nanoparticulates technology have emerged as alternatives for site specific chemotherapy. Among the different types of nanoparticulates, lipid nanoemulsions and nanoparticles have several advantages for topical delivery of poorly soluble chemotherapeutics. These particles show sustained drug release and protection of loaded drugs from chemical degradation. This technology is promising to enhance the intracellular concentration of drugs and consequently reduce the cytotoxicity of skin chemotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据